Public Citizen's health and safety work protects consumers by advocating for safer, more effective drugs, medical devices and other products; equitable health care services and more physician accountability; safer cars and trucks; and improvements in worker safety. View the Health Research Group's work listed chronologically.
The National Institutes of Health (NIH) exposed 1,316 premature infants to increased risk of blindness and death as part of a clinical trial - known as the SUPPORT study - without parents of the babies being informed of the risks to their babies.
Apr 01 - Release of First Comprehensive State Occupational Safety and Health Standards Database
Mar 31 - Letter to FDA on the Off-Label Promotion of Several Diabetes Drugs
Mar 27 - Presentation at the FDA’s Public Meeting on the Proposed Rule Regarding Generic Drug Labeling
Mar 19 - Testimony Before a Joint Meeting of the FDA’s Pulmonary-Allergy Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Regarding Fluticasone Furoate/Vilanterol (Breo Ellipta) for Asthma
Mar 16 - Letter to the Association for the Accreditation of Human Research Protection Programs Regarding the University of Minnesota’s Human Research Protection Program
Mar 16 - Letter to OHRP Regarding the University of Minnesota’s Human Research Protection Program
Please wait while my tweets load
If you can't wait - click here
Look up in the sky! Caped SEC Chief urged to curb campaign cash - Bloomberg
Opposition continues against proposed FDA generic label rule - Modern Healthcare
Kudos for White House plan on resistant bacteria - MedPage Today
Global Trade Watch
Health Research Group
Copyright © 2015 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.
Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.
Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.
You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.